Home
Celiac DiseaseMedia
Celiac disease impacts approximately 0.7% (confirmed by biopsy) to 1.4% of the global population (based on positive results for celiac disease antibodies)[1], yet it remains significantly underdiagnosed. This autoimmune condition, triggered by gluten ingestion, can lead to severe intestinal damage,
This study assesses the analytical performance of a novel automated immunoassay microarray for autoantibodies associated with Celiac Disease. Presented at ACG 2024.
In this webinar, Celiac Disease is discussed with particular focus on advances in the diagnosis and how a multiplex approach to serological testing can support the identification of the disease.